IL6 and inflammatory bowel disease: Considering that TG expression with the risk alleles in the colon correlated with the development of ICRPs in MDs, TG-mediated activation of the IL-6 amplifier in the intestine may contribute to the high concurrent occurrence of thyroidal disease and inflammatory bowel disease in human patients (53–56).